Expert Financial Analysis and Reporting

Recent Reports

• Cytokinetics: Update on Extensive Clinical Trials Being Conducted (CYTK, Buy, $9.45) (0)

Recent Blogs

• Update on Currently Recommended Stocks of SmithOnStocks.com (0)
• Cryoport: Updated Sales and Earnings Model (CYRX, Buy, $9.69) (0)
• Novartis Releases Three Month Interim Data for JULIET Trial of CTL-019 in r/r DLBCL (0)
• Antares: Recent Launch of Makena Subcu Auto Injector and Probable Launches of Xyosted and AB Rated Generic to EpiPen Could Make for an Outstanding Price Performance in 2018 (ATRS, Buy, $2.36) (0)
• FDA Announces July 12 AdCom Meeting for CTL-019: Thoughts on How This Might Affect Investor Perceptions of Kite (KITE, Neutral, $80.25) and Cryoport (CYRX, Buy, $3.89) (0)
• AMAG:  It Is Early Days, but the Launch of the Subcutaneous Dosage Form of Makena Seems to be Going Very Well (AMAG, Buy, $21.17) (0)
• Northwest Biotheraputics to Make Presentation at ASCO Today Monday June 5, 2017 (0)
• Portola: Approval of AndexXa is a Major Positive (PTLA, Buy, $41.19) (0)
• Key Investment Considerations Relating to Much Anticipated CAR-T Product Launches By Kite and Novartis Later This Year (0)
• AMAG: Upgrading to Buy Based on an In-Depth Analysis of the Outlook for Makena Over the 2018 to 2020 Period (AMAG, Buy, $21.10)) (0)
• Cytokinetics: Comments on the Upside Move Today (CYTK, Buy, $12.90) (0)

Social Feeds

• • $cyrx New detailed sales and earnings model for CYRX https://t.co/nxCRnB0WRI, May 16
  • $PTLA Why I think that it is probable that AndexXa will be approved on May 4, 2018 PDUFA date https://t.co/U1VUXy7M4g, Mar 15
  • $NWBO I believe the survival tail of DCVax-L. will be much critical .to regulatory approval than proscribed endpoin… https://t.co/1tdPY1pS2Z, Feb 15
  • $NWBO I have just published a new report called Two Lead Investigators on DCVax-L Phase 3 Trial Believe That It Cou… https://t.co/No23NLuaFu, Jan 09
  • $nwbo Coorection to prior tweet should read Issues to Focus on in Pending Manuscript Dealing with Blinded Data from… https://t.co/CoM1PILQ8w, Jan 05